Johnson Johnson news and trends

Robots Redefine Surgical Landscape for Enhanced Patient Outcomes
Healthcare // April 23, 2024

The integration of robotics is reshaping surgical procedures, promising enhanced precision, efficiency, and improved patient outcomes.  Recent earnings reports from industry giants like Intuitive Surgical and Johnson & Johnson (J&J) shed light on the growing demand for robotic-assisted solutions, underlining a shift in the medical technology (MedTech) landscape....

Johnson & Johnson Amplifies MedTech Profile in Q1 Earnings
Earnings // April 16, 2024

Johnson & Johnson (J&J) has emphasized the pivotal role of medical technology (MedTech) in advancing healthcare. During a Tuesday (April 16) call with analysts to discuss the first quarter (Q1) and full-year 2023 financial results, the pharmaceutical giant underscored its commitment to bolstering its reputation as...

J&J Sees Surge in MedTech Sales Post-Kenvue Split 
Healthcare // January 23, 2024

Six months after parting ways with its consumer health unit, Kenvue, Johnson & Johnson has reported total sales of $21.4 billion for the last quarter of 2023, a 7.3% increase from the corresponding quarter in 2022.  The pharmaceutical giant disclosed a net income of $4.13 billion,...

J&J’s Medical Device Sales Feel the Side Effects of Weight-Loss Drugs 
Healthcare // October 17, 2023

Riding high, Johnson & Johnson reported pharmaceutical sales worth $13.89 billion on Tuesday (Oct 17), a year-over-year growth exceeding 5%.  The pharmaceuticals driving its growth are Darzalex, a biologic used for multiple myeloma, and Erleada, a prostate cancer treatment, in addition to several other oncology...

Interviews & Exclusives
CE 100 Index Loses 2.2% as Short Sellers Target C3.ai and Airbnb 

April 10, 2023
Short sellers — who profit when stocks decline — held sway this past week. The CE 100 Stock Index slipped 2.2% as only one pillar gained ground in a holiday-shortened week.   The Move segment, work pillar and Enablers group were all down a respective 4.7%, 4% and 3.6%. Short-Seller Reports Grab Headlines Within the Enablers […]

Digital Pivots Help Johnson & Johnson’s Supply Chain Stay Resilient

June 02, 2021
In many ways, Johnson & Johnson was at the heart of the COVID-19 crisis. Not only was the company racing against the virus to deploy a vaccine, but it was...

Crafting The Better B2B ‘Customer’ Experience

October 06, 2020
“April is the cruelest month,” wrote TS Eliot. His calendar was bit off. At least insofar as 2020 has shaped up, and especially where B2B payments have been concerned. March...

Quick Reads
Johnson & Johnson Spinoff Kenvue Valued at $41 Billion in IPO

May 04, 2023
Johnson & Johnson’s consumer healthcare spinoff has made the biggest U.S. initial public offering (IPO) since 2021. Kenvue, which includes Band-Aid and several other well-known consumer brands that had been part of Johnson & Johnson, raised $3.8 billion in an IPO that valued it at $41 billion Thursday (May 4), CNBC reported Thursday. That was […]

Johnson & Johnson Prepares to Test IPO Waters

April 23, 2023
Johnson & Johnson is reportedly readying an investors roadshow to take its commercial healthcare unit public. According to a Sunday (April 23) Wall Street Journal (WSJ) report, sources familiar with...

Apple Unveils AFib Apple Watch Study As It Eyes Health For Growth

February 25, 2020
As it views health as an important sector for growth, Apple has been putting down the foundation to roll out new studies and health features in its offerings. The tech...

Apple, Johnson & Johnson Eye Preventative Healthcare

January 18, 2019
Apple is partnering with Johnson & Johnson’s Janssen Pharmaceuticals unit to study whether the Apple Watch can be used to prevent strokes. According to Venture Beat, the study is focusing...